Search Results - "Malfroy, M."

The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service by Wells, A. W., Llewelyn, C. A., Casbard, A., Johnson, A. J., Amin, M., Ballard, S., Buck, J., Malfroy, M., Murphy, M. F., Williamson, L. M.

“…This study provides data on National Blood Service (NBS) red blood cell (RBC, n = 9142), platelet (PLT, n = 4232) and fresh frozen plasma (FFP, n = 3584)…”
Get full text

TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression by Parroche, P, Roblot, G, Le Calvez-Kelm, F, Tout, I, Marotel, M, Malfroy, M, Durand, G, McKay, J, Ainouze, M, Carreira, C, Allatif, O, Traverse-Glehen, A, Mendiola, M, Pozo-Kreilinger, J J, Caux, C, Tommasino, M, Goutagny, N, Hasan, U A

“…Toll-like receptor 9 (TLR9) recognizes bacterial, viral or cell damage-associated DNA, which initiates innate immune responses. We have previously shown that…”
Get full text

The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studies by Llewelyn, C. A., Wells, A. W., Amin, M., Casbard, A., Johnson, A. J., Ballard, S., Buck, J., Malfroy, M., Murphy, M. F., Williamson, L. M.

“…summary Previous studies of blood use have used different methods to obtain and classify transfusion indications. Before undertaking a national study of…”
Get full text

LB1657 Tie-2 expressing monocytic myeloid-derived suppressor cells represent a resistance mechanism to anti-PD-1 therapy in melanoma by Marguier, A., Nardin, C., Ndao, B., Wespiser, M., Pereira, V., Laheurte, C., Lecoester, B., Malfroy, M., Boullerot, L., Aubin, F., Adotévi, O.

Get full text

Using patient-identifiable data for epidemiological research by Malfroy, M., Llewelyn, C. A., Johnson, T., Williamson, L. M.

“…The use of patient‐identifiable data in epidemiological research is subject to increasingly complex regulation. This article reports the experience of a…”
Get full text

KS01.6.A UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM by Carpentier, A F, Verlut, C, Ghiringhelli, F, Bronnimann, C, Ursu, R, Fumet, J, Gherga, E, Lefort, F, Belin, C, Vernerey, D, Mathieu Larroquette, M, Hervieu, A, Laheurte, C, Meurisse, A, Jacquin, M, Malfroy, M, Kroemer, M, Clairet, A, Fagnoni-Legat, C, Lehmann-Che, J, Boullerot, L, Cuzzubbo, s, Adotevi, O

Get full text

210P Anti-CTLA-4 overcomes inhibitory effect of PD1high regulatory T cell on circulating antitumor CD4+ Th1 response in patients treated by anti-PD(L)-1 by Marguier, A., Perreira, V., Wespiser, M., Lecoester, B., Boullerot, L., Malfroy, M., Nardin, C., Laheurte, C., Orillard, E., Adotevi, O.

Get full text

Breast cancer‐derived transforming growth factor‐β and tumor necrosis factor‐α compromise interferon‐α production by tumor‐associated plasmacytoid dendritic cells by Sisirak, Vanja, Vey, Nelly, Goutagny, Nadège, Renaudineau, Sarah, Malfroy, Marine, Thys, Sandra, Treilleux, Isabelle, Labidi‐Galy, Sana Intidhar, Bachelot, Thomas, Dezutter‐Dambuyant, Colette, Ménétrier‐Caux, Christine, Blay, Jean‐Yves, Caux, Christophe, Bendriss‐Vermare, Nathalie

“…We previously reported that plasmacytoid dendritic cells (pDCs) infiltrating breast tumors are impaired for their interferon‐α (IFN‐α) production, resulting in…”
Get full text

203P Early remodeling of systemic antitumor T cell immunity in head and neck cancer patients treated by chemoradiation by Lecoester, B., Seffar, E., Marguier, A., Renaudin, A., Richard, T., Wespiser, M., Malfroy, M., Boullerot, L., Arnier, R., Martin, E., Sun, X., Laheurte, C., Boustani, J., Adotevi, O.

Get full text

LBA6 UCPVax therapeutic vaccination promotes cytotoxic and Th1 polarized antitumor CD4 T cells and epitope spreading in patients with advanced non-small cell lung cancer by Adotevi, O., Laheurte, C., Boullerot, L., Malfroy, M., Richard, T., Cuche, L., Seffar, E., Kaulek, V., Jacquin, M., Orillard, E., Eberst, G., Jandus, C., Westeel, V., Borg, C., Godet, Y.

Get full text

180P Recalling pre-existing microbiota-specific T cells to target tumors by Carpier, J-M., Talpin, A., Kulakowski, G., Dos Santos Leite, A.M., Laviolette, K., Noguerol, J., Mersceman, T., Garnier, A., Gaal, C., Pereira Oliveira, C., Calderon, C., Boullerot, L., Malfroy, M., Strozzi, F., Gouttefangeas, C., Adotevi, O., Joffre, O., Gamelas Magalhaes, J., Chêne, L., Bonny, C.

Get full text

Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers by Saulnier, Amandine, Vaissière, Thomas, Yue, Jiping, Siouda, Maha, Malfroy, Marine, Accardi, Rosita, Creveaux, Marion, Sebastian, Sinto, Shahzad, Naveed, Gheit, Tarik, Hussain, Ishraq, Torrente, Mariela, Maffini, Fausto Antonio, Calabrese, Luca, Chiesa, Fausto, Cuenin, Cyrille, Shukla, Ruchi, Fathallah, Ikbal, Matos, Elena, Daudt, Alexander, Koifman, Sergio, Wünsch-Filho, Victor, Menezes, Ana M.B., Curado, Maria-Paula, Zaridze, David, Boffetta, Paolo, Brennan, Paul, Tommasino, Massimo, Herceg, Zdenko, Sylla, Bakary S.

“…The DOK1 gene is a putative tumour suppressor gene located on the human chromosome 2p13 which is frequently rearranged in leukaemia and other human tumours. We…”
Get full text

TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16INK4a protein expression by Parroche, P, Roblot, G, Le Calvez-Kelm, F, Tout, I, Marotel, M, Malfroy, M, Durand, G, McKay, J, Ainouze, M, Carreira, C, Allatif, O, Traverse-Glehen, A, Mendiola, M, Pozo-Kreilinger, J J, Caux, C, Tommasino, M, Goutagny, N, Hasan, U A

“…Toll-like receptor 9 (TLR9) recognizes bacterial, viral or cell damage-associated DNA, which initiates innate immune responses. We have previously shown that…”
Get full text

Cytosteatonecrosis: a pseudophlegmonic form in 2 newborn infants by Beyer, P, Mandard, J C, Malfroy, M

Get more information

Pulmonary stenosis in adults with intact interventricular septum by Gerard, R, Arnoux, M, Malfroy, M, Jouve, A

Get more information

Acrodermatitis enteropathica. Case in a 2-year-old child presenting beta-2 A-globulin deficiency by Beyer, P, Wasmer, A, Peter, M, Malfroy, M L

Get more information